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Abstract
Purpose: Haemangioblastomas (HABLs) and pilocytic astrocytomas (PAs) are brain tumours presenting similar ap-
pearance and location in conventional magnetic resonance (MR) imaging. The purpose of our study was to determine 
whether a detailed analysis of diffusion (DWI) and perfusion (PWI) characteristics can be useful in preoperative 
differentiation of these tumours.
Material and methods: The study group consisted of biopsy proven six HABLs and six PAs, which underwent preop-
erative standard MR examinations including PWI and DWI. In PWI relative cerebral blood volume (rCBV) and the 
shape of perfusion curves (parameters of peak height – rPH and percentage of signal recovery – rPSR) were analysed. 
All perfusion parameters were measured for the entire tumour core (mean rCBV, mean rPH, mean rPSR) and in 
regions with maximal values (max rCBV, max rPH, max rPSR). In DWI parameters of apparent diffusion coefficient 
(ADC) from the entire tumour core (mean ADC) and in regions with minimal values (min ADC) were evaluated.
Results: Compared to PAs, HABLs presented significantly higher rCBV and rPH values and lower mean rPSR value. 
PAs showed significantly lower rCBV and rPH values and higher mean rPSR value. Mean rCBV showed no overlap 
in the values between HABLs and PAs, and thus it provided the highest accuracy in differentiating between them. 
Max rPSR, mean ADC, and min ADC did not show any significant differences.
Conclusions: High rCBV values and deep perfusion curves with only partial return to the baseline are characteristic 
features of HABLs differentiating them from PAs, which show lower rCBV values and perfusion curves overshooting 
the baseline. Diffusion parameters are not useful in differentiation of these tumours.
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Introduction
Cerebellar haemangioblastomas (HABLs) and pilocytic as-
trocytomas (PAs) are two types of brain tumours that show 
similar appearance in conventional magnetic resonance 
(MR) imaging, typically presenting as a cyst with an as-
sociated mural nodule. Both of them are usually clinically 
benign and are classified as grade I by the World Health 
Organisation (WHO). The patient’s age is often helpful in 
distinguishing these tumours associating HABLs with adult 
patients and PAs with the paediatric population, but it is not 
always reliable [1, 2]. Nevertheless, there is a group of young 
adults in whom both types of tumours may occur. Haeman-
gioblastomas account for 1-2.5% of intracranial tumours 
and 7-12% of posterior fossa neoplasms in adult patients 
[3, 4]. Pilocytic astrocytomas are the most common paediatric 
central nervous system (CNS) gliomas and one of the most 
common paediatric cerebellar tumours representing 60% 
of all astrocytomas in children [2]. They may also occur in 
adults, reaching in this group 2.3-6% of all brain tumours [1]. 
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Morphologically, both HABLs and PAs may show hete-
rogeneous appearance; mainly cystic but also solid-cystic 
or solid lesions are observed [3, 4]. 
Both tumours are potentially curable by surgical re-
section and are associated with longer survival [5]. How-
ever, their histopathological structure has an impact on 
different clinical and surgical approaches. Since HABLs 
represent capillary-rich neoplasms of the CNS with large 
networks of tightly packed blood vessels lined by endothe-
lial cells on a background of abundant connective tissue 
[6], their surgical resection should encompass the whole 
tumour capsule, otherwise it could lead to high mortality 
and morbidity rates due to the complication of excessive 
bleeding [3, 7]. Sometimes preoperative embolisation of 
the feeding arteries may reduce the tumour blood sup-
ply, which can decrease intraoperative haemorrhage [8]. 
On the other hand, PAs, as less vascularised tumours, are 
composed of a variable combination of loose connective 
glial tissue, compacted piloid tissue, numerous vacuoles, 
microcysts, and sometimes macrocysts [6], so their poten-
tial complete resection is easier and safer. 
As presented above, the reliable preoperative differen-
tiation between HABLs and PAs is important but, in many 
cases, challenging in the standard MR imaging. 
Advanced MR techniques such as perfusion-weighted 
imaging (PWI) and diffusion-weighted imaging (DWI) 
may add functional information and help in the in vivo 
characterisation of these two tumour types. 
Perfusion-weighted imaging is the method that brings 
information on cerebral physiology at the capillary level 
(microvasculature) [9, 10]. Among the PWI techniques 
dynamic susceptibility contrast (DSC) MR imaging is the 
most often used. DSC MRI provides maps of cerebral blood 
volume (CBV) and noninvasive measurements of relative 
cerebral blood volume (rCBV) [9, 10] as well as perfusion 
curves, which give an insight into the dynamics of the first 
pass of the contrast material through the microvasculature. 
Analysis of perfusion curves has been reported to be very 
useful in the evaluation of brain tumours [9, 10], in some 
cases more important than analysis of the CBV maps [10]. 
Two haemodynamic parameters derived from perfusion 
curves: the peak height (PH) and the percentage of signal 
intensity recovery (PSR), have been shown to provide im-
portant, additional information regarding tumor capillary 
volume and capillary permeability respectively [10]. 
On the other hand, DWI is a sensitive tool that allows 
quantifying of physiological alterations in water diffusion, 
which result from microscopic structural changes not de-
tectable with anatomical MR imaging. Water diffusion can 
be measured with a parameter of apparent diffusion coef-
ficient (ADC) [11, 12]. Diffusivity of water depends pri-
marily on the presence of microscopic structural barriers 
in tissue such as membranes of cell bodies, axons, and my-
elin sheaths but also viscosity of adjacent structures that 
can alter the random motion of water molecules. Highly 
cellular tumours show areas of restricted diffusion with 
low ADC values, thus ADC is regarded as a marker of 
tumour cellularity [11, 12]. 
In the literature there are a few reports that compare 
HABLs and PAs in advanced MR techniques, but none 
of them focuses on both DWI and PWI together in one 
study. The purpose of our study was to determine whether 
a detailed analysis of diffusion and perfusion character-
istics with the evaluation of perfusion curves is useful in 
preoperative differentiation of these tumours.
Material and methods
The study group consisted of 12 solitary brain tumours, 
which were selected from a cohort of 1210 subjects with 
CNS tumours evaluated with T2*DSC perfusion and diffu-
sion MR in our institution between January 2010 and July 
2017. Our material was subdivided into biopsy proven six 
HABLs (three men, three women) aged 32-73 years (mean 
age: 52 years) and six PAs (one man, five women) aged 14-
67 years (mean age: 36 years). All tumours were solitary 
lesions located either infra- or supratentorially (Table 1).
Data acquisition
All examinations were performed on 1.5 T MR scanner 
(Signa Hdx, GE Medical Systems) using a 16-channel HNS 
(head-neck-spine) coil. 
Before contrast administration a standard MR exami-
nation was carried out including axial T1-weighted imag-
es, axial, coronal, and sagittal T2-weighted images as well 
as axial FLAIR images followed by DWI and post-contrast 
DSC T2*-perfusion and 3D T1-weighted imaging. 
During the whole MR examination the patients were 
instructed to keep their eyes closed. No sedation or anaes-
thesia were used in any of the patients.
Perfusion examination was performed with a dynamic 
susceptibility contrast (DSC) method using fast echopla-
nar T2*-weighted gradient echo sequence with the follow-
ing parameters: TR = 1.900 ms, TE = 80 ms, FOV = 30 cm, 
matrix = 192 × 128, slice thickness = 8 mm without spac-
ing, NEX – 1.0. Ten seconds after the start of the im-
age acquisition a bolus of 1.0 mol/l gadobutrol formula 
(Gadovist, Bayer Health Care, Germany) in a dose of 
0.1 ml/kg of body weight was injected via a 20-gauge 
catheter placed in the antecubital vein. Contrast was ad-
ministered with an automatic injector (Medrad) at a rate 
of 5 ml/s and was followed by a saline bolus (20 ml at 
5 ml/s). The whole perfusion imaging lasted 1 min 26 s, 
in which sets of images from 13 axial slices were obtained 
before, during and after contrast injection. After PWI 
a post-contrast T1-weighted 3D sequence was performed 
using contrast bolus administered earlier for the perfusion 
examination. No contrast agent was administered before 
DSC perfusion MR imaging. 
Diffusion imaging was performed using a transverse 
single-shot echoplanar diffusion-weighted sequence with 
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the following parameters: TE = 89.9 ms, TR = 8000 ms, 
slice thickness = 5 mm, FOV = 26 cm, matrix size = 128 
× 128, NEX – 1, diffusion sensitive gradient b = 1000 s/
mm2 in three basic orthogonal directions, scanning time: 
42 seconds. 
Data postprocessing
In all cases the morphological assessment of the lesions 
was performed on T1, T2-weighted, and post-contrast 
T1-weighted images using visual inspection.
The diffusion and perfusion weighted images were 
postprocessed using Functool software (ADW 4.4; GE 
Medical Systems).
Perfusion weighted imaging analysis
The analysis was based on evaluation of CBV parame-
ters on CBV maps (Fig. 1) as well as values of PH (peak 
height) and PSR (percentage of signal recovery) derived 
from perfusion curves. Measurements of CBV were per-
formed by placing ROIs on the CBV maps fused with 
post-contrast T1-weighted images to accurately assess the 
tumour core (Fig. 1). PSR and PH were calculated from 
the perfusion curves based on the following formulas: 
PSR = (S1 – Smin)⁄PH
PH = Smin – S0, 
where: S0 – start of contrast passage, Smin – maximal 
drop of magnetic susceptibility, and S1 – measurement 
after 24 seconds from Smin (Fig. 1). All CBV, PH, and 
PSR values were normalised to values from the normal 
appearing white matter of the contralateral hemisphere to 
obtain relative values of all parameters: rCBV, rPH, rPSR.
In each tumour measurements of mean values of all 
perfusion parameters for the whole tumour core (mean 
rCBV, mean rPH, mean rPSR) and maximal values of 
these parameters (max rCBV, max rPH, max rPSR) were 
assessed. Mean values for the whole tumour were ob-
tained by manual outlining of the entire lesion on each 
slice (Fig. 1) avoiding foci of haemorrhage or necrosis and 
calculating the arithmetical means from all the measured 
values. Maximal values were obtained by placing small 
Table 1. Demographic and imaging characteristics of haemangioblastomas and pilocytic astrocytomas
Patient Age (years) Sex Location Morphology Enhancement
Haemangioblastomas
1 73 Female Cerebellum Cystic with mural nodule Homogenous
2 49 Female Cerebellum Solid Homogenous
3 37 Male Cerebellum Cystic with mural nodule Homogenous
4 63 Male Cerebellum Solid with necrosis Inhomogenous
5 57 Female Suprasellar region Solid Homogenous
6 32 Male Peripheral, in the right temporal lobe Solid with necrosis Inhomogenous-peripheral
Pilocytic astrocytomas
1 14 Female Cerebellum Cystic-solid with necrosis Inhomogenous
2 63 Female Cerebellum Solid Homogenous-peripheral 
3 25 Female Cerebellum Solid Inhomogenous
4 23 Female Pperipheral, in the right frontal lobe Solid Homogenous
5 67 Male Peripheral, in the left parietal lobe Solid with necrosis Inhomogenous-peripheral
6 26 Female Suprasellar region Solid with necrosis Inhomogenous
Figure 1. Haemangioblastoma in the left cerebellar hemisphere: (A) a post-contrast, T1-weighted image, (B) an ADC map, (C) a CBV map, (D) a perfusion 
signal intensity time curve. The ADC (B) and CBV (C) maps show placement of large irregular freehand ROIs outlining the tumour core (purple) as well as 
small circular ROIs within the big ROIs (green). The perfusion curve (D) shows haemodynamics of contrast agent during the first pass of a bolus through the 
brain vasculature, with the x-axis reflecting time in seconds and y-axis indicating signal intensity
A B C D
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ROIs (40-60 mm2) within several hot spots on each slice. 
The highest value from all ROIs was chosen as the tu-
moural maximal value (Fig. 1).
Diffusion-weighted imaging analysis
Measurements of ADC for the entire tumour (mean 
ADC) and measurements of minimum ADC (min ADC) 
were performed on ADC maps fused with post-contrast 
T1-weighted images. Similarly to perfusion evaluation, 
mean ADC values were obtained by manual outlining of 
the entire enhancing tumour core on each slice (Fig. 1), 
avoiding foci of haemorrhage or necrosis, and then by 
calculating the arithmetical averages from all measured 
ADC values. Min ADC values were measured using small 
ROIs (40-60 mm2) located within the large freehand ROIs 
(Fig. 1). The lowest value from all ROIs was chosen as the 
tumoural minimum ADC value described as min ADC. 
Statistical analysis
All data obtained in the study were statistically analysed us-
ing the Statistica PL software package version 4.0. Quanti-
tative perfusion and diffusion data were compared between 
HABL and PA groups using the student t-test, with a p val-
ue below 0.05 set as the level of significance. 
Results
Both HABLs and PAs were mainly located intra-axially in 
the cerebellum, although tumours in the supratentorial or 
extra-axial locations were also found (Table 1).
Based on standard MR examination HABLs and PAs 
presented variable morphology, both cystic and solid 
(Table 1, Figs. 2 and 3). Compared to PAs, HABLs more 
often showed typical appearance of a cyst with a mural 
nodule as well as homogenous enhancement (Table 1, 
Fig. 2). On the other hand, the majority of PAs were solid 
with areas of necrosis and inhomogeneous enhancement 
(Table 1, Fig. 3). 
All HABLs presented very high perfusion parameters 
of mean rCBV (6.44), max rCBV (12.01), mean rPH (5.31), 
max rPH (9.00) as well as low values of mean rPSR (0.21) 
and max rPSR (0.53), indicating only a slight return of the 
perfusion curve to the baseline level. Compared to HABLs, 
PAs showed significantly lower mean rCBV (2.14), max 
Figure 2. Two examples of haemangioblastomas in the cerebellum presenting as a cystic tumour with a mural nodule (A) and as a more solid tumour (D) 
on post-contrast T1-weighted images. CBV maps (B and E) show high perfusion values indicated by red colour while perfusion curves (C and F) present 
only partial return to the baseline level (red lines)
A
D
B
E
C
F
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Table 2. Perfusion and diffusion measurements with the results of group comparisons indicated by p-value
Patient mean rCBV max rCBV mean rPH max rPH mean rPSR max rPSR mean ADC min ADC
Haemangioblastomas
1 8.22 10.91 5.58 10.32 0.30 0.36 1.73 1.41
2 5.1 9.10 5.1 9.65 0.30 0.98 0.81 0.76
3 6.75 10.50 6.64 8.34 0.42 0.45 1.67 1.29
4 9.13 22.07 5.90 9.65 0.20 0.70 1.68 1.31
5 3.74 4.85 3.51 4.07 -0.40 0.10 1.88 1.63
6 5.71 14.61 5.13 11.99 0.46 0.56 1.11 0.69
Mean 6.44 12.01 5.31 9.00 0.21 0.53 1.48 1.18
Pilocytic astrocytomas
1 1.34 2.64 3.65 4.84 5.04 5.84 1.14 0.84
2 2.67 3.54 2.51 3.21 0.97 1.00 0.84 0.65
3 2.93 9.62 2.72 8.05 0.43 1.07 1.62 1.06
4 1.27 1.82 2.11 2.38 1.83 1.84 1.05 0.94
5 3.34 6.34 1.94 3.51 1.10 1.12 1.00 0.70
6 1.30 1.81 1.82 2.07 1.71 1.74 1.05 0.82
Mean 2.14 4.30 2.46 4.01 1.85 2.10 1.11 0.84
p-value 0.0007* 0.01* 0.0002* 0.005* 0.03* 0.06 0.1 0.06
*Statistically significant values
Figure 3. Two examples of pilocytic astrocytomas presenting as cystic-nodular (A) and solid tumours (D) on post-contrast T1-weighted images. CBV maps 
(B and E) show low perfusion values indicated by green and blue colours while perfusion curves (C and F) present return above the baseline level (red lines)
A
D
B
E
C
F
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rCBV (4.30), mean rPH (2.46), and max rPH (4.01) as well as 
significantly higher mean rPSR (1.85) and max rPSR (2.10) 
(Table 2). There were overlaps in parameters of max rCBV, 
mean rPH, max rPH, mean rPSR, and max rPSR but no 
overlap in the values of mean rCBV. Mean rCBV was found 
to be a parameter showing the highest accuracy in distin-
guishing these two analysed types of tumours (Table 2). 
In DWI the values of mean ADC and min ADC were 
slightly higher in the HABL group (1.48 and 1.18, respec-
tively) than in PAs (1.11 and 0.84, respectively). Moreover, 
there was an overlap in ADC values between HABLs and 
PAs (Table 2). No statistically significant differences were 
observed between average values of these parameters.
Discussion
Regarding the typical morphological appearance of both 
tumours as a cystic mass with enhancing mural nodule 
located in the cerebellum, our observations on conven-
tional MR examination demonstrated many exceptions 
in both tumour location and morphology. In our study 
only one third of HABLs showed the typical morpho-
logical appearance as a cystic mass with a mural nod-
ule located in the cerebellum (Table 1, Fig. 2). Brundl 
et al. [3] analysed the morphology of 12 HABLs, report-
ing eight of them to have a typical appearance, which was 
66.7% of the study group, whereas Kumar et al. [6] pre-
sented 50% of HABL tumours as typically appearing. Ana-
lysing PA cases, half of them were located extracerebellar-
ly. The majority of PAs appeared solid and inhomogenous 
and only one case presented typically as a cystic mass 
with an enhancing nodule in the cerebellum (comprising 
only ~16.7% of our PA cases) (Table 1, Fig. 3). A study by 
Burkhard et al. [2] also analysed the location of PAs and 
showed that minority of cases (around 42%) were located 
typically in the cerebellum. Moreover, Burkhard et al. [2] 
observed the tendency of PAs in children under 12 years 
old to be located typically in the cerebellum, contrary to 
adult patients. On the other hand, Stüer et al. [1] reported 
that only 21% of PAs presented a typical morphological 
appearance as a cystic mass with a mural nodule. 
The variations and similarities in the presentation 
of HABLs and PAs reported in the literature [1-3, 6, 8] 
coincide with our results and experience. It proves the 
importance of advanced MR techniques such as PWI 
and DWI, which can provide additional information on 
a microstructural level, which may in turn help in the dif-
ferentiation between both tumour types in terms of their 
vascularisation and cellularity.
In our study we used PWI to evaluate tumour vascu-
larisation and DWI to assess cellularity. Analysing per-
fusion studies we found significant differences between 
HABLs and PAs regarding both rCBV values derived from 
rCBV maps as well as shapes of perfusion curves.
 Compared to PAs, HABLs showed significantly higher 
values of mean CBV and max CBV (Table 2, Figs. 2 and 3), 
reflecting their high vascularisation. The parameter of 
rCBV was also evaluated by several other authors, and 
our results are in agreement with these studies [6, 8, 13]. 
It must be stressed that in our study mean rCBV was 
the only perfusion parameter without any overlap in the 
values between two tumour types, with a range of 1.27-
3.34 in PAs and 3.74-9.13 in HABLs, and therefore mean 
rCBV may be regarded as the parameter with the highest 
accuracy in distinguishing between both tumours. 
In our opinion, analysis of perfusion curves may also 
be useful in differentiation between HABLs and PAs be-
cause these two tumour types show different shapes of 
signal intensity time curves. Our study revealed that in 
HABLs the signal drop described as PH was more pro-
nounced, in contrast to PAs where the signal drop was 
relatively small (Table 2, Figs. 2 and 3). The differences in 
both mean rPH and max rPH were statistically significant 
with p-values 0.0002 and 0.005, respectively. Moreover, in 
HABLs signal recovery described as rPSR was less pro-
nounced, with only partial return of the perfusion curve 
to the baseline level. In our study the majority of PA cas-
es showed the signal time intensity curves crossing the 
baseline (overshooting) after the first pass; however, only 
mean rPSR values reached the level of significance.
Our results of the PH parameter are in agreement with 
the study by She et al. [14], who also showed statistically 
higher values of PH in HABLs than in PAs. On the other 
hand, the results of our PSR analysis only partially remain 
in agreement with the above mentioned study by She et al. 
[14], who found both max rPSR and mean rPSR to be high-
er in PA. 
The differences in either rCBV or rPH values between 
HABLs and PAs may be explained easily by the distinct his-
tological features of these two tumour types. As mentioned 
before, HABLs have abundant tumour vessels within lesions 
shown by high rCBV values and more pronounced signal 
drop reflected in rPH values, whereas PAs are sparsely vas-
cularised in a wide interstitial space contributing to less pro-
nounced perfusion curves and lower rCBV values [6, 14].
The explanation of PSR characteristics in both tu-
mours is complicated because it is influenced by many 
factors, including the permeability of capillaries, the 
amount of contrast agent leakage, the rate of blood flow, 
as well as the size of extravascular space [14, 15]. More-
over, the signal intensity is connected with the complex 
T1- and T2*-shortening effect from the accumulation of 
contrast agent in the interstitial space of lesion. When the 
T1-shortening effects, due to accumulation of contrast 
agent in the interstitial space, overwhelm the T2*-short-
ening effects, the signal intensity increases and even ex-
ceeds the baseline level [14, 15]. The significant difference 
in the mean rPSR between HABLs and PAs in this study 
may suggest that contrast agent leakage into the interstitial 
space in PAs is more pronounced than that in HABLs [8]. 
In our study DWI was proved to be a less specific and 
sensitive method in differentiation HABLs from PAs with 
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no statistical significance. However, HABLs presented 
higher values of both mean ADC as well as min ADC in 
comparison to PAs (Table 2). Higher ADC values may be 
explained by a lower rate of cellularity in HABLs com-
pared to PAs, and it may suggest the diagnosis of HABL 
in the posterior cranial fossa [16]. On the other hand, the 
results of ADC values in HABLs as well as in PAs appear 
similar to other benign tumours, which is consistent with 
previous reports [8, 17, 18] and may help in differentia-
tion from high grade tumours (Table 2). 
Conclusions
Perfusion measurements are more useful than diffusion 
parameters in differentiation between HABLs and PAs. 
High rCBV values and deep perfusion curves with 
only partial return to the baseline measured within the 
whole enhancing tumour part characterise HABLs and 
enable differentiation of them from PAs showing lower 
rCBV values and the curve overshooting the baseline. 
The mean rCBV value showed no overlap in the values 
between HABLs and PAs, and thus it provided the highest 
accuracy in distinguishing between these tumour types. 
Perfusion MR, as an easy to perform and rapid tech-
nique, should be routinely used in differentiation of brain 
focal lesions, including distinguishing HABLs from PAs. 
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